Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$74,779,428
-$6,631,896 QoQ
Shares Held
1,157,039
-4.4% QoQ
Ownership
0.975%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.31255558369251.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6874444163074883.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. HALO ranks #18 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in HALO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,779,428 | 1,157,039 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $81,411,324 | 1,209,678 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $78,938,406 | 1,076,335 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,447,791 | 873,660 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $53,123,863 | 832,532 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,328,092 | 759,843 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $47,952,178 | 837,739 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $24,382,635 | 465,673 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,517,396 | 307,704 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,727,462 | 73,795 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,816,714 | 73,736 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,780,887 | 77,097 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,471,327 | 536,039 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $60,567,943 | 1,064,463 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $42,154,858 | 1,066,132 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,281,504 | 688,216 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,664,630 | 41,741 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,766,503 | 43,932 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,653,436 | 40,645 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $323,999 | 7,135 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $276,821 | 6,640 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $263,435 | 6,168 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||